Modified or targeted release formulations of linaclotide
作者： Ahmad Hashash
DOI:
关键词:
摘要: The present invention relates to delayed release pharmaceutical compositions comprising linaclotide or pharmaceutically acceptable salts thereof, as well various methods and processes for the preparation use of compositions.
lens.org 参考文章(6)
Atsushi Muro, Mare Nishiura, Kanehira Imai, Kenichi Ashihara, Tsukasa Nishikawahara, Granular Pharmaceutical Composition ,(2012)
Angelika Fretzen, Brian Cali, Yun Mo, Mahendra Dedhiya, Stable formulations of linaclotide ,(2011)
Angelika Fretzen, Mahendra Dedhiya, Steven Witowski, Hong Zhao, Alfredo Grossi, Yun Mo, Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration ,(2009)
Angelika Fretzen, Mahendra Dedhiya, Steven Witowski, Hong Zhao, Alfredo Grossi, Yun Mo, Formulations comprising linaclotide ,(2010)
Angelika Fretzen, Anil Chhettry, Mahendra Dedhiya, Steven Witowski, Hong Zhao, Alfredo Grossi, Yun Mo, Orally Disintegrating Compositions of Linaclotide ,(2010)
Angelika Fretzen, Anil Chhettry, Yun Mo, Mohammad Mafruhul Bari, Matthew Miller, Ritesh Sanghvi, Andreas Grill, Ahmad Hashash, Mahendra Dedhiya, Mark G. Currie, Delayed Release Compositions of Linaclotide ,(2014)